Zhao Ding
Directeur Général chez SICHUAN HUIYU PHARMACEUTICAL CO., LTD.
Fortune : 224 M $ au 31/05/2024
Postes actifs de Zhao Ding
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SICHUAN HUIYU PHARMACEUTICAL CO., LTD. | Président | 01/11/2018 | - |
| Directeur Général | 12/10/2010 | - | |
| Fondateur | 12/10/2010 | - | |
| Directeur/Membre du Conseil | 12/10/2010 | 01/11/2018 | |
TYK Medicines, Inc.
 TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Directeur/Membre du Conseil | 01/01/2024 | - |
Historique de carrière de Zhao Ding
Formation de Zhao Ding
| University of Cambridge | Doctorate Degree |
Statistiques
Internationale
| Chine | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SICHUAN HUIYU PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
TYK Medicines, Inc.
TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |
